Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens.

Repana D, Nulsen J, Dressler L, Bortolomeazzi M, Venkata SK, Tourna A, Yakovleva A, Palmieri T, Ciccarelli FD.

Genome Biol. 2019 Jan 3;20(1):1. doi: 10.1186/s13059-018-1612-0.


Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.

Beddowes E, Spicer J, Chan PY, Khadeir R, Corbacho JG, Repana D, Steele JP, Schmid P, Szyszko T, Cook G, Diaz M, Feng X, Johnston A, Thomson J, Sheaff M, Wu BW, Bomalaski J, Pacey S, Szlosarek PW.

J Clin Oncol. 2017 Jun 1;35(16):1778-1785. doi: 10.1200/JCO.2016.71.3230. Epub 2017 Apr 7.


Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer.

Wulaningsih W, Wardhana A, Watkins J, Yoshuantari N, Repana D, Van Hemelrijck M.

Cochrane Database Syst Rev. 2016 Feb 12;2:CD008593. doi: 10.1002/14651858.CD008593.pub3. Review.


Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma.

Repana D, Ross P.

Diseases. 2015 Oct 28;3(4):294-305. doi: 10.3390/diseases3040294. Review.


Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site.

Hyphantis T, Papadimitriou I, Petrakis D, Fountzilas G, Repana D, Assimakopoulos K, Carvalho AF, Pavlidis N.

Psychooncology. 2013 Sep;22(9):2009-15. doi: 10.1002/pon.3244. Epub 2013 Jan 29.


Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.

Fountzilas G, Kourea HP, Bobos M, Televantou D, Kotoula V, Papadimitriou C, Papazisis KT, Timotheadou E, Efstratiou I, Koutras A, Pentheroudakis G, Christodoulou C, Aravantinos G, Miliaras D, Petraki K, Papandreou CN, Papakostas P, Bafaloukos D, Repana D, Razis E, Pectasides D, Dimopoulos AM.

Anticancer Res. 2011 Sep;31(9):3007-18. Erratum in: Anticancer Res. 2011 Oct;31(10):3637. Dosage error in article text.


A case-control study on the rs3130932 single nucleotide polymorphism in the OCT4B translation initiation codon in association with cancer state.

Katafigiotis S, Papamichos SI, Katopodi R, Papazisis K, Mylonaki E, Repana D, Kotoula V, Karavidopoulou Y, Agorastos T, Tarlatzis BC, Lambropoulos AF.

Eur J Cancer Prev. 2011 May;20(3):248-51. doi: 10.1097/CEJ.0b013e32834474c7.


Supplemental Content

Loading ...
Support Center